Last reviewed 2026-04-19 · How we verify

Infectious disorder of joint

Approved treatments

• Ramycin
  Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins.
• Garamycin · Merck & Co.
• Eryped · Arbor Pharms Llc
• Cefradex · Bristol-Myers Squibb
• Cefaprin · Bristol-Myers Squibb
• Ancef In Sodium Chloride 0.9% In Plastic Container · GSK
• Ancef In Sodium Chloride 0.9% In Plastic Container · GSK
  Cefazolin is an antibacterial drug that inhibits bacterial cell wall synthesis.
• Cleocin T · Pfizer
  Cleocin T works by inhibiting protein synthesis in bacteria, preventing them from producing essential proteins and ultimately leading to cell death.
• Vancocin · ANI Pharmaceuticals
• Cleocin · Generic (originally Upjohn/Pfizer)
  Lincosamide antibiotic that binds the 50S ribosomal subunit, inhibiting bacterial protein synthesis with excellent anaerobic coverage.
• Metro I.V. In Plastic Container · Baxter
• Pipracil
  Pipracil works by inhibiting bacterial cell wall synthesis, ultimately leading to cell lysis and death.
• Ciprofloxacine · Poitiers University Hospital
• Gentamicin · Merck & Co.
• Cefadole
  Cefadole works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
• Ceftriaxon · Centre Hospitalier Universitaire Vaudois
• Primaxin · Merck Sharp & Dohme B.V.
  Primaxin works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
• Arikayce Kit · Bristol-Myers Squibb
  Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria.
• Fortaz · Pai Holdings Pharm
  Fortaz works by binding to penicillin-binding proteins on bacterial cell walls, preventing them from forming a strong cell wall and ultimately leading to bacterial cell death.
• Mefoxin In Sodium Chloride 0.9% In Plastic Container
• Monocid
• Primaxin · Merck & Co.
  Primaxin works by inhibiting the action of dehydropeptidase, an enzyme that breaks down certain antibiotics, thereby protecting them from degradation and allowing them to reach effective concentrations in the body.
• AZLOCILLIN · Bayer Pharmaceuticals Corp
• Cephalotin · Eli Lilly
• Keflex · Shionogi
• Zinacef · GSK
  Zinacef works by inhibiting bacterial cell wall synthesis, ultimately leading to bacterial cell death.
• Kanacin · Bristol-Myers Squibb
• Fortaz · Pai Holdings Pharm
  Bactericidal agent inhibiting bacterial cell wall synthesis with beta-lactamase resistance.
• Noroxin
• Floxin
• Epocelin
• Cipro · Bayer AG
• Rocephin · Generic (originally Roche)
• Cephradin · Sohag University
• Cephazolin · HaEmek Medical Center, Israel
• Cefazoline · Nantes University Hospital
• Ceftazidim · Tel-Aviv Sourasky Medical Center
• Metronidazol · University of Oslo
• Ofloxacine · Assistance Publique - Hôpitaux de Paris

Competitive intelligence

For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:

• Infectious disorder of joint patent landscape — cliff calendar, originator estates, attackable patents
• Infectious disorder of joint treatment landscape brief
• Infectious disorder of joint treatment updates RSS

Frequently asked questions about Infectious disorder of joint

Related

• Treatment landscape: Infectious disorder of joint patent cliff · Infectious disorder of joint CI report
• Treatment: Ramycin
• Treatment: Garamycin · Merck & Co.
• Treatment: Eryped · Arbor Pharms Llc
• Treatment: Cefradex · Bristol-Myers Squibb
• Treatment: Cefaprin · Bristol-Myers Squibb
• All diseases: Browse the disease index · Disease landscape hub

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing